Replies to post #120866 on Biotech Values

[oldberkeley]

What's amazing is the pump and dump boards have very little DD. This Martin guy has professionals analyzing the short "thesis" and he was unsuccessful with AVNR yesterday. NEOP was just over bought that's all. It will rebound.

I'm confused. Are you suggesting that evaluating a biotech company with the phrase "just overbought" is an example of DD?